Immunotherapy's hidden danger: study probes blood vessel damage in cancer patients

NCT ID NCT07535944

First seen Apr 22, 2026 · Last updated May 16, 2026 · Updated 2 times

Summary

This study looks at how immune checkpoint inhibitors, a type of cancer immunotherapy, may affect blood vessels. Researchers will measure artery stiffness in 200 cancer patients before and after starting treatment to see if these drugs increase the risk of vascular problems. The goal is to better understand side effects and improve patient safety.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for VASCULAR COMPLICATIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.